Were Hedge Funds Right About Neurocrine Biosciences, Inc. (NBIX)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Neurocrine Biosciences Inc (NBIX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
5 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 5 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Neurocrine Biosciences, Inc. (NBIX) Fell Out Of Favor With Hedge Funds
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
15 Best Stocks to Buy for 2022 According to Analysts
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Hedge Funds Are Coming Back To Neurocrine Biosciences, Inc. (NBIX)
Is Neurocrine Biosciences, Inc.
Hedge Funds Never Been Less Bullish On Neurocrine Biosciences, Inc. (NBIX)
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is NBIX Stock A Buy or Sell?
In this article you are going to find out whether hedge funds think Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is a good investment right now.
Is NBIX A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is Neurocrine Biosciences (NBIX) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Was The Smart Money Wrong About Neurocrine Biosciences, Inc. (NBIX)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
